Vestibulodynia, localised provoked vulvodynia at the vestibule Urological and Genital Diseases
Conditions
Interventions
Patients were randomly and blindly assigned into one of two groups to receive diazepam or placebo vaginal tablet. Identical vaginal tablet containing 5 mg of diazepam or placebo, were received from th
VerityMedical, London, UK) was used, which produces a symmetrical biphasic wave and has three customizable mode programs.The stimulationwas delivered through a commercially available plastic vaginal p
Sponsors
Italian Vulvodynia Association (Associazione Italiana Vulvodinia)
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1. Diagnosis of Vestibulodynia (VBD) 2. At least 18 years of age 3. Diagnosed with moderate or severe pelvic floor tone hypertonic disfunction
Exclusion criteria
Exclusion criteria: 1. Allergy to diazepam or any benzodiazepine 2. Currently pregnant 3. Have any contraindication to diazepam
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain modification, assessed using VAS and Dispareunya score Measured from baseline to 60 days | — |
Secondary
| Measure | Time frame |
|---|---|
| Modification of pelvic floor muscle measurements, via assessment of variation in pelvic floor muscles parameters and vestibular nerve fibers current perception threshold | — |
Countries
Italy, Jamaica
Outcome results
None listed